Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells - Ye, Z; Liu, C F; Lanikova, L (Stem Cells, 2014)
, et al.